Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery
Status:
Completed
Trial end date:
2019-10-02
Target enrollment:
Participant gender:
Summary
Bleeding after thoracic surgery is a major cause of perioperative hemodynamic instability and
transfusion requirement, which can lead to a rise of morbidity, mortality and costs.
The objective of this study is to evaluate the efficiency of tranexamic acid (TA) in the
prevention of perioperative bleeding in thoracic hemorrhagic surgery.